AMLX Class Action Alert: Robbins LLP Reminds Investors of Pending Lead Plaintiff Deadline – April 9, 2024 – in Amylyx Pharmaceuticals, Inc. Class Action Robbins LLP is investigating the allegations that Amylyx Pharmaceuticals, Inc. (AMLX) misled investors regarding RELYVRIO's commercial prospects.

AMLX STOCK NEWS: Lead Plaintiff Deadline is Approaching in Class Action Against Amylyx Pharmaceuticals, Inc.; Contact Robbins LLP for Information Robbins LLP is Investigating the Allegations that Amylyx Pharmaceuticals, Inc. (AMLX) Misled Investors Regarding the Viability of its Drug for Treating ALS

AMLX Class Action Alert: Robbins LLP Reminds Shareholders of Lead Plaintiff Deadline in the Class Action Against Amylyx Pharmaceuticals, Inc. Robbins LLP is Investigating the Allegations Against Amylyx Pharmaceuticals Inc.

Investor Notice: Robbins LLP Informs Investors of Class Action Filed Against Amylyx Pharmaceuticals, Inc. (AMLX)   Robbins LLP is Investigating the Allegations Against Amylyx Pharmaceuticals, Inc.